Enlarged tonsils / adenoids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 1–14 years old; 2. ASA classification I–II; 3. Children undergoing tonsil and/or adenoid removal under general anesthesia (tracheal intubation).
Exclusion criteria
Exclusion criteria: 1. Children who are allergic to the components of Oseli; 2. Children with acute upper respiratory tract infection symptoms before the operation; children with a history of bronchial asthma; 3. Children with existing or potential difficult airway conditions as assessed before the operation; 4. Children with related mental or neurological disorders and difficult to evaluate the analgesic effect; 5. Children with a history of chronic pain or long-term use of painkillers; 6. Children with other conditions that the researchers consider unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxalidine inhibits the ED50 and ED95 of the cardiovascular response to tracheal intubation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of cough after injection of oxalidine;Success rate of sedation;Hemodynamic changes before and after intubation;In the PACU, the PAED and FLACC scores; | — |
Countries
China
Contacts
Guangzhou Women and Children Medical Center Liuzhou Hospital